Literature DB >> 4043081

Human alpha-L-iduronidase. 1. Purification, monoclonal antibody production, native and subunit molecular mass.

P R Clements, D A Brooks, G T Saccone, J J Hopwood.   

Abstract

Human alpha-L-iduronidase from liver was purified about 20 000-fold with a new rapid three-step, five-column procedure which consisted of a Concanavalin-A-Sepharose/Blue-A-Agarose coupled step, a CM-Sepharose/Bio-Gel HT coupled step followed by a cupric-ion-chelating Sepharose 6B step. The behaviour of alpha-L-iduronidase on gel permeation chromatography was dependent upon both pH and ionic strength of the eluting buffer. The formation of species with enzyme activity which behaved as large-molecular-mass aggregates was favoured under conditions of low ionic strength and neutral pH. The amount of high-Mr species diminished as the pH decreased or the ionic strength increased to favour a single active species of Mr 65 000. A specific monoclonal antibody was generated against liver alpha-L-iduronidase. The antibody specifically immunoprecipitated enzyme activity from both crude and purified sources. The subunit Mr of liver alpha-L-iduronidase was estimated to be 65 000 using SDS-PAGE. Monoclonal antibody immunoprecipitation of radiolabelled enzyme was used to provide definitive confirmation of this subunit size.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043081     DOI: 10.1111/j.1432-1033.1985.tb09158.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  20 in total

1.  Immunoquantification of the low abundance lysosomal enzyme N-acetylgalactosamine 4-sulphatase.

Authors:  D A Brooks; P A McCourt; G J Gibson; J J Hopwood
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16.3.

Authors:  H S Scott; L J Ashton; H J Eyre; E Baker; D A Brooks; D F Callen; G R Sutherland; C P Morris; J J Hopwood
Journal:  Am J Hum Genet       Date:  1990-11       Impact factor: 11.025

3.  Human liver iduronate-2-sulphatase. Purification, characterization and catalytic properties.

Authors:  J Bielicki; C Freeman; P R Clements; J J Hopwood
Journal:  Biochem J       Date:  1990-10-01       Impact factor: 3.857

4.  Human alpha-L-iduronidase. Catalytic properties and an integrated role in the lysosomal degradation of heparan sulphate.

Authors:  C Freeman; J J Hopwood
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

5.  Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients.

Authors:  L J Ashton; D A Brooks; P A McCourt; V J Muller; P R Clements; J J Hopwood
Journal:  Am J Hum Genet       Date:  1992-04       Impact factor: 11.025

Review 6.  Review: the immunochemical analysis of enzyme from mucopolysaccharidoses patients.

Authors:  D A Brooks
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Human liver N-acetylglucosamine-6-sulphate sulphatase. Purification and characterization.

Authors:  C Freeman; P R Clements; J J Hopwood
Journal:  Biochem J       Date:  1987-09-01       Impact factor: 3.857

8.  Human liver N-acetylgalactosamine 6-sulphatase. Purification and characterization.

Authors:  J Bielicki; J J Hopwood
Journal:  Biochem J       Date:  1991-10-15       Impact factor: 3.857

9.  alpha-L-iduronidase in normal and mucopolysaccharidosis-type-I human skin fibroblasts.

Authors:  J A Taylor; G J Gibson; D A Brooks; J J Hopwood
Journal:  Biochem J       Date:  1991-02-15       Impact factor: 3.857

10.  Recombinant alpha-L-iduronidase: characterization of the purified enzyme and correction of mucopolysaccharidosis type I fibroblasts.

Authors:  E G Unger; J Durrant; D S Anson; J J Hopwood
Journal:  Biochem J       Date:  1994-11-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.